July 2016 FDA Recall Drug by Teva North America
D-1453-2016 - Failed Content Uniformity Specifications

This Class III drug recall was voluntarily initiated by Teva North America on July 15, 2016 for the product Drug. The FDA reported the reason for recall as failed content uniformity specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1453-2016

Reason for Recall
Failed Content Uniformity Specifications: out of specification test result for spray content uniformity.
Initiated
07-15-2016
Reported
08-10-2016
Quantity
193,320 canisters

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Children's Qnasl 40 mcg (beclomethasone dipropionate) Nasal Aerosol, 40 mcg per spray, 60 Metered Sprays per canister, 4.9g Net Contents, Rx only; Professional Sample; Manufactured for Teva Respiratory, LLC, Horsham, PA 19044; By: 3M Drug Delivery Systems, Northridge, CA 91324; NDC 59310-206-08.

Batch or Lot Expiration Information

Lot# 150328, Exp 10/17